A case of right simple unilateral renal ectopia with left malrotated kidney in 26 years old female is presented with a brief review of literature. Right ectopic kidney was located between 4th and 5th lumber vertebra Numerous aberrant vessels of ectopic kidney disclosed during nephroureterectomy.
Adult ; Female ; Humans ; Kidney ; Spine

Adrenoal adenomas are relatively rare tumor in retroperi toneum, most cases are nonsteroid-producing and 1-5 cm in diameter. Herein a case of large adrenal adenoma is presented with a brief review of literatures.
Adenoma*

A clinical observation was made on 282 patients with tumors of the genitourinary tract during the period from Jan. 1978 to Mar. 1982. The results were as follows: 1. 282 of the 1457 inpatients (19.35%) were the patients with tumor of the genitourinary tract. Men with thetumor were predominated (male to female: 17.8:1). 2. Prostate was the most commonly involved organ (66.8%) and the bladder. kidney, ureter, penis were followed. 3. Age was ranged from 8 months to 84 years, showing the highest incidence in the 8th decade (39.3%) andover 50 years old were 89.3%. 4. Urinary retention was the most common symptom (34.7%) and dysuria, gross hematuria, palpable mass were followed. 5. On histologic examination, begin prostatic hyperplasia was the most common (66.9%) and transitional cell carcinoma of the bladder, adenocarcinoma of the prostate, renal cell carcinoma. squamous cell carcinoma ofthe penis were followed. 6. 223 of the 282 patients with tumor (79.1%) were performed various type of operation. Transurethral surgerywas the most commonly performed (46.2%).
Adenocarcinoma ; Carcinoma, Renal Cell ; Carcinoma, Squamous Cell ; Carcinoma, Transitional Cell ; Dysuria ; Female ; Hematuria ; Humans ; Incidence ; Inpatients ; Kidney ; Male ; Middle Aged ; Penis ; Prostate ; Prostatic Hyperplasia ; Ureter ; Urinary Bladder ; Urinary Retention

No abstract available.
Leukemia, Monocytic, Acute* ; Leukemic Infiltration* ; Lymphatic Diseases* ; Skin*

Enteric duplications are uncommon congenital anomalies. Duplications of the stomach account for only 3.8% of gastrointestinal duplication. More particularly, duplications involving the pylorus are extremely rare. These are characterized by firm attachment to at least one point of the alimentary tract with a well developed coat of smooth muscle and mucous membrane. The most frequent presentation is an abdominal mass with vomiting, mainly discovered during the first year of life. We experienced a 24-day-old boy with non-bilous, non-projectile vomiting and palpable abdominal mass, clinically similar to hypertrophic pyloric stenosis. He was diagnosed as having gastropyloric duplication cyst by abdominal ultrasonography, upper gastrointestinal series and abdominal computerized tomography. Thus we report a newborn infant with gastric outlet obstruction secondary to a duplication of the pylorus which is a rare cause of gastric obstruction.
Gastric Outlet Obstruction ; Humans ; Infant, Newborn* ; Male ; Mucous Membrane ; Muscle, Smooth ; Pyloric Stenosis, Hypertrophic ; Pylorus* ; Stomach ; Ultrasonography ; Vomiting

OBJECTIVE: This study evaluated the possible role of 2 additional tumor markers to CA125 in discriminating between benign and malignant ovarian tumors. METHODS: Serum samples from 1,346 patients were obtained on seven days before operation. All patients underwent surgery for ovarian tumors. Serum levels of 3 tumor markers were compared to histology. Concentrations of tumor markers (CA125, CA72-4, CA19-9) were detected by enzyme immuno- or immunoradiometric assays. Normal range of these markers was defined as CA125 Humans ; Immunoradiometric Assay ; Reference Values ; Sensitivity and Specificity ; Biomarkers, Tumor*

OBJECTIVE: To evaluate the usefulness of percutaneous umbilical blood sampling (PUBS) and prevalence of fetal infection in the pregnant women with suspicious fetal rubella infection. METHODS: Between June 1996 and May 2002 in Chonnam National University Hospital, the rubella specific IgG, IgM antibody and RT-PCR were checked in fetal blood obtained from 31 pregnant women with high risk of rubella infection. Eighteen women (58.1%) had rubella specific IgM, 11 women (35.5%) high titer of rubella specific IgG, and 2 women had a history of recent rubella vaccination within 3 months. RESULTS: PUBS was performed in all cases, successful in 27 cases (87.1%) and failed in 4 cases (12.9%). Cardiocentesis was performed in failed cases. Performing the PUBS, fetal bradycardia was observed in 7 cases (25.9%), fetal tachycardia in 1 case (14.8%), and preterm labor in 2 cases (7.4%). Performing cardiocentesis, fetal bradycardia was observed in 1 case (25.0%), fetal tachycardia in 2 cases (50.0%), and preterm labor in 1 case (25.0%). There was no fetal death. All samples of fetal blood were positive for rubella specific IgG but rubella specific IgM was detected in only 1 case. RT-PCR was negative in all cases. CONCLUSION: Fetal blood sampling is relatively safe and a great precaution is necessary before termination of pregnancy with suspicious fetal rubella infection and without typical maternal rash to reduce unnecessary termination of pregnancy. Several tests such as rubella specific IgM and PCR from placental villi, amniotic fluid, and fetal blood should be considered before termination of pregnancy.
Amniotic Fluid ; Bradycardia ; Chorionic Villi ; Cordocentesis* ; Exanthema ; Female ; Fetal Blood ; Fetal Death ; Humans ; Immunoglobulin G ; Immunoglobulin M ; Jeollanam-do ; Obstetric Labor, Premature ; Polymerase Chain Reaction ; Pregnancy ; Pregnant Women* ; Prenatal Diagnosis* ; Prevalence ; Rubella* ; Tachycardia ; Vaccination

Malignant mixed Mullerian tumor(MMMT) of the ovary is very uncommon neoplasm consisting of both a sarcomatous and carcinomatous component. These tumors usually present in an advanced stage and are characterized by rapid growth and poor survival and appropriate treatment remained controversial. The patients with advanced stage ovarian cancer could only benefit from an optimal surgical debulking. However, the optimal cytoreductive surgery may often be difficult to achieve due to the initial extent of the disease. Thus primary surgery for this subset of patients may be questionable. So, we tried neoadjuvant Taxol and/or cis-platinum combined chemotherapy as primary treatment. At the end of neoadjuvant chemotherapy, the patient showed markedly decrease of serum CA 125 level(from 210 U/ml to 59 U/ml) and optimal cytoreductive surgery was performed. After surgery, adjuvant chemotherapy was administered and the serum CA 125 level decreased to the normal range. This case shows our experience of neoadjuvant chemotherapy followed by cytoreductive surgery and adjuvant chemotherapy in patient with primarily unresectable ovarian malignant mixed Mullerian tumor(MMMT).
Chemotherapy, Adjuvant ; Cisplatin ; Drug Therapy* ; Female ; Humans ; Ovarian Neoplasms ; Ovary ; Paclitaxel ; Reference Values

Malignant mixed Mullerian tumor(MMMT) of the ovary is very uncommon neoplasm consisting of both a sarcomatous and carcinomatous component. These tumors usually present in an advanced stage and are characterized by rapid growth and poor survival and appropriate treatment remained controversial. The patients with advanced stage ovarian cancer could only benefit from an optimal surgical debulking. However, the optimal cytoreductive surgery may often be difficult to achieve due to the initial extent of the disease. Thus primary surgery for this subset of patients may be questionable. So, we tried neoadjuvant Taxol and/or cis-platinum combined chemotherapy as primary treatment. At the end of neoadjuvant chemotherapy, the patient showed markedly decrease of serum CA 125 level(from 210 U/ml to 59 U/ml) and optimal cytoreductive surgery was performed. After surgery, adjuvant chemotherapy was administered and the serum CA 125 level decreased to the normal range. This case shows our experience of neoadjuvant chemotherapy followed by cytoreductive surgery and adjuvant chemotherapy in patient with primarily unresectable ovarian malignant mixed Mullerian tumor(MMMT).
Chemotherapy, Adjuvant ; Cisplatin ; Drug Therapy* ; Female ; Humans ; Ovarian Neoplasms ; Ovary ; Paclitaxel ; Reference Values

No abstract available.
Pregnancy*